Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Daily versus as-needed fluticasone furoate nasal spray in allergic rhinitis
TCTR20170310002Phase 4Completed
- Sponsor
- Siriraj Research Development Fund
- Start
- Oct 2017
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of fluticasone in allergic rhinitis (AR), sponsored by Siriraj Research Development Fund. Started Oct 2017; status: completed.
02
Drugs
fluticasone
03
Conditions
allergic rhinitis (AR)
Beyond the preview
Go deeper on TCTR20170310002.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20170310002.